These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 32370259)

  • 1. Senescence and Cancer: Role of Nitric Oxide (NO) in SASP.
    Mabrouk N; Ghione S; Laurens V; Plenchette S; Bettaieb A; Paul C
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32370259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescent Cells in Cancer Therapy: Friends or Foes?
    Wang B; Kohli J; Demaria M
    Trends Cancer; 2020 Oct; 6(10):838-857. PubMed ID: 32482536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Senescent cells in cancer therapy: why and how to remove them.
    Zhang JW; Zhang D; Yu BP
    Cancer Lett; 2021 Nov; 520():68-79. PubMed ID: 34237406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Response to Therapy-Induced Senescence: A Matter of Dose and Timing.
    Mongiardi MP; Pellegrini M; Pallini R; Levi A; Falchetti ML
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33513872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing Functional Roles of the Senescence-Associated Secretory Phenotype (SASP).
    Malaquin N; Tu V; Rodier F
    Methods Mol Biol; 2019; 1896():45-55. PubMed ID: 30474839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Keeping the senescence secretome under control: Molecular reins on the senescence-associated secretory phenotype.
    Malaquin N; Martinez A; Rodier F
    Exp Gerontol; 2016 Sep; 82():39-49. PubMed ID: 27235851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The senescence-associated secretory phenotype (SASP) from mesenchymal stromal cells impairs growth of immortalized prostate cells but has no effect on metastatic prostatic cancer cells.
    Alessio N; Aprile D; Squillaro T; Di Bernardo G; Finicelli M; Melone MA; Peluso G; Galderisi U
    Aging (Albany NY); 2019 Aug; 11(15):5817-5828. PubMed ID: 31412320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Role of Senotherapy in Cancer: A Comprehensive Review.
    Malayaperumal S; Marotta F; Kumar MM; Somasundaram I; Ayala A; Pinto MM; Banerjee A; Pathak S
    Clin Pract; 2023 Jul; 13(4):838-852. PubMed ID: 37489425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies.
    Xu J; Zhou L; Liu Y
    Front Pharmacol; 2020; 11():601325. PubMed ID: 33362554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of extracellular vesicles as a senescence-associated secretory phenotype: Insights into the pathophysiology of lung diseases.
    Kadota T; Fujita Y; Yoshioka Y; Araya J; Kuwano K; Ochiya T
    Mol Aspects Med; 2018 Apr; 60():92-103. PubMed ID: 29146100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The senescence-associated secretory phenotype and its physiological and pathological implications.
    Wang B; Han J; Elisseeff JH; Demaria M
    Nat Rev Mol Cell Biol; 2024 Apr; ():. PubMed ID: 38654098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Potential Role of Senescence As a Modulator of Platelets and Tumorigenesis.
    Valenzuela CA; Quintanilla R; Moore-Carrasco R; Brown NE
    Front Oncol; 2017; 7():188. PubMed ID: 28894697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular senescence: a double-edged sword in cancer therapy.
    Xiao S; Qin D; Hou X; Tian L; Yu Y; Zhang R; Lyu H; Guo D; Chen XZ; Zhou C; Tang J
    Front Oncol; 2023; 13():1189015. PubMed ID: 37771436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct phenotypes and 'bystander' effects of senescent tumour cells induced by docetaxel or immunomodulatory cytokines.
    Sapega O; Mikyšková R; Bieblová J; Mrázková B; Hodný Z; Reiniš M
    Int J Oncol; 2018 Nov; 53(5):1997-2009. PubMed ID: 30226595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-TNF-α treatment modulates SASP and SASP-related microRNAs in endothelial cells and in circulating angiogenic cells.
    Prattichizzo F; Giuliani A; Recchioni R; Bonafè M; Marcheselli F; De Carolis S; Campanati A; Giuliodori K; Rippo MR; Brugè F; Tiano L; Micucci C; Ceriello A; Offidani A; Procopio AD; Olivieri F
    Oncotarget; 2016 Mar; 7(11):11945-58. PubMed ID: 26943583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protein kinase D1-mediated classical protein secretory pathway regulates the Ras oncogene-induced senescence response.
    Su Y; Wang P; Shen H; Sun Z; Xu C; Li G; Tong T; Chen J
    J Cell Sci; 2018 Mar; 131(6):. PubMed ID: 29420297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting normal and cancer senescent cells as a strategy of senotherapy.
    Sikora E; Bielak-Zmijewska A; Mosieniak G
    Ageing Res Rev; 2019 Nov; 55():100941. PubMed ID: 31408714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α.
    Su Y; Xu C; Sun Z; Liang Y; Li G; Tong T; Chen J
    Aging (Albany NY); 2019 Jan; 11(2):549-572. PubMed ID: 30670674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype.
    Jakhar R; Crasta K
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Senescence-Associated Secretory Phenotype: Critical Effector in Skin Cancer and Aging.
    Ghosh K; Capell BC
    J Invest Dermatol; 2016 Nov; 136(11):2133-2139. PubMed ID: 27543988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.